
MSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in India
MSD Pharma gets CDSCO panel nod for New Indications of Pembrolizumab in India We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link